monoclonal-porphyrins (Quadra Logic)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemonoclonal-porphyrins (Quadra Logic)

Drug Alias NameMAb-porphyrins (QLT)MAb-porphyrins (Quadra Logic)monoclonal-porphyrins (QLT)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionImmunomodulators

TargetsUpdating

Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesArthritis, Rheumatoid +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovelion Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovelion Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesArthritis, Rheumatoid +[4]

Other Information

ATC CodeN/A